1. Controlling a human parainfluenza virus-3 outbreak in a haematology ward in a tertiary hospital
- Author
-
Iglόi, Z., van Loo, I. H. M., Demandt, A. M. P., Franssen, K., Jonges, M., van Gelder, M., Erkens-Hulshof, S., van Alphen, L. B., MUMC+: DA MMI Staf (9), Med Microbiol, Infect Dis & Infect Prev, MUMC+: DA MMI Infectieserologie (9), MUMC+: DA MMI AIOS (9), Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, RS: CAPHRI - R4 - Health Inequities and Societal Participation, Medical Microbiology and Infection Prevention, and AII - Infectious diseases
- Subjects
Microbiology (medical) ,Adult ,Paramyxoviridae Infections ,Human parainfluenza 3 ,Outbreak ,The Netherlands ,General Medicine ,Hematology ,CELL TRANSPLANT RECIPIENTS ,Disease Outbreaks ,Parainfluenza Virus 3, Human ,Tertiary Care Centers ,RESPIRATORY-SYNCYTIAL-VIRUS ,TYPE-3 ,Infectious Diseases ,INFECTION ,NOSOCOMIAL OUTBREAK ,Nosocomial infections ,Humans ,EPIDEMIOLOGY ,Pathology, Molecular ,CROATIA ,REAL-TIME PCR ,Haematology ,Retrospective Studies - Abstract
Background: The human parainfluenza virus 3 (HPIV-3) outbreak at the haemato-oncology ward of the Maastricht University Medical Centre in the summer of 2016. Aim: To describe an effective strategy to control the largest reported HPIV-3 outbreak at an adult haematology–oncology ward in the Netherlands by implementing infection control measures and molecular epidemiology investigation. Methods: Clinical, patient and diagnostic data were both pro- and retrospectively collected. HPIV-3 real-time polymerase chain reaction (HPIV-3 RT-PCR) was validated using oropharyngeal rinse samples. Screening of all new and admitted patients was implemented to identify asymptomatic infection or prolonged shedding of HPIV-3 allowing cohort isolation. Findings: The HPIV-3 outbreak occurred between 9 July and 28 September 2016 and affected 53 patients. HPIV-3 RT-PCR on oropharyngeal rinse samples demonstrated an up to 10-fold higher sensitivity compared with pharyngeal swabs. Monitoring showed that at first positive PCR, 20 patients (38%) were asymptomatic (of which 11 remained asymptomatic) and the average duration of shedding was 14 days (range 1–58). Asymptomatic patients had lower viral load, shorter period of viral shedding (≤14 days) and were mostly immune-competent oncology patients. The outbreak was under control five weeks after implementation of screening of asymptomatic patients. Conclusion: Implementation of a sensitive screening method identified both symptomatic and asymptomatic patients which had lower viral loads and allowed early cohort isolation. This is especially important in a ward that combines patients with varying immune status, because both immunocompromised and immune-competent patients are likely to spread the HPIV-3 virus, either through prolonged shedding or through asymptomatic course of disease.
- Published
- 2022